Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |